메뉴 건너뛰기




Volumn 70, Issue 1, 2002, Pages 204-210

Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; PHAGE C33; PHAGE ENB6; UNCLASSIFIED DRUG; VANCOMYCIN;

EID: 0036139176     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.1.204-210.2002     Document Type: Article
Times cited : (410)

References (19)
  • 3
    • 0000937686 scopus 로고
    • Tests for linear trends in proportions and frequencies
    • (1955) Biometrics , vol.2 , pp. 375-386
    • Armitage, P.1
  • 5
    • 2042510935 scopus 로고    scopus 로고
    • FDA approves the antibiotic synercid for limited clinical uses
    • (1999) ASM News , vol.65 , pp. 800-801
    • Cimons, M.1
  • 10
    • 0029661181 scopus 로고    scopus 로고
    • Phage therapy revisited: The population biology of a bacterial infection and its treatment with bacteriophage and antibiotics
    • (1996) Am. Nat. , vol.147 , pp. 881-898
    • Levin, B.1    Bull, J.J.2
  • 13
    • 0034699917 scopus 로고    scopus 로고
    • Phage therapy - Advantages over antibiotics?
    • (2000) Lancet , vol.356 , pp. 1418
    • Pirisi, A.1
  • 15
  • 17
    • 0028233662 scopus 로고
    • Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa
    • (1994) Burns , vol.20 , pp. 209-211
    • Soothill, J.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.